InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Davis Blaine, Chief Financial Officer. Officer active across 1 companies, notably Protara Therapeutics, Inc.. In total, 2 disclosures have been recorded. The latest transaction was filed on 3 January 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
014,100 shares0
Common Stock
SEC:0001209191-22-001715:0·
014,100 shares0
Common Stock
SEC:0001209191-22-001715·
2 of 2 declarations
About Davis Blaine
Blaine Davis is the Chief Financial Officer of Protara Therapeutics, Inc. In this role, he is responsible for the financial management of the company, including financial planning and compliance. His expertise in finance and accounting is essential to ensure the financial health of Protara Therapeutics. Blaine Davis plays a key role in making strategic financial decisions and optimizing the company's performance.
